GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CuraScientific Corp (OTCPK:CSTF) » Definitions » EV-to-FCF

CuraScientific (CuraScientific) EV-to-FCF : -4.75 (As of May. 13, 2024)


View and export this data going back to . Start your Free Trial

What is CuraScientific EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, CuraScientific's Enterprise Value is $1.45 Mil. CuraScientific's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.31 Mil. Therefore, CuraScientific's EV-to-FCF for today is -4.75.

The historical rank and industry rank for CuraScientific's EV-to-FCF or its related term are showing as below:

CSTF' s EV-to-FCF Range Over the Past 10 Years
Min: -36.74   Med: -4.91   Max: -1.63
Current: -4.75

During the past 3 years, the highest EV-to-FCF of CuraScientific was -1.63. The lowest was -36.74. And the median was -4.91.

CSTF's EV-to-FCF is ranked worse than
100% of 511 companies
in the Drug Manufacturers industry
Industry Median: 23.55 vs CSTF: -4.75

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-13), CuraScientific's stock price is $0.0002. CuraScientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $0.027. Therefore, CuraScientific's PE Ratio for today is 0.01.


CuraScientific EV-to-FCF Historical Data

The historical data trend for CuraScientific's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CuraScientific EV-to-FCF Chart

CuraScientific Annual Data
Trend Dec20 Dec21 Dec22
EV-to-FCF
-10.19 -4.85 -12.28

CuraScientific Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.25 -12.28 -5.88 -34.89 -13.48

Competitive Comparison of CuraScientific's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, CuraScientific's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CuraScientific's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CuraScientific's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where CuraScientific's EV-to-FCF falls into.



CuraScientific EV-to-FCF Calculation

CuraScientific's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1.448/-0.305
=-4.75

CuraScientific's current Enterprise Value is $1.45 Mil.
CuraScientific's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CuraScientific  (OTCPK:CSTF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

CuraScientific's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0002/0.027
=0.01

CuraScientific's share price for today is $0.0002.
CuraScientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.027.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


CuraScientific EV-to-FCF Related Terms

Thank you for viewing the detailed overview of CuraScientific's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


CuraScientific (CuraScientific) Business Description

Traded in Other Exchanges
N/A
Address
51544 Cesar Chavez Street, Suite No. 1J, Coachella, CA, USA, 92236
CuraScientific Corp manufactures commercial chemicals with a variety of commercial sterilization applications for agriculture, warehousing, hospitality, and medical facilities. The company's product, DiOx+, is a disinfectant sterilizer that kills harmful pathogens without exposing people or the environment to dangerous toxins.
Executives
Paul Quentin Goyette director 2205 LOCH WAY, EL DORADO HILLS CA 95762
William Joseph Reed director, officer: Chief Executive Officer 333 N UNIVERSITY AVE., #33, REDLANDS CA 92374
Johann Loewen director C/O METHES ENERGIES INTERNATIONAL LTD, 3651 LINDELL ROAD, SUITE D-272, LAS VEGAS NV 89103
Edouard Maurice Beaudette director 13480 N BLOOMFIELD ROAD, NEVADA CITY CA 95959
Justin Michael Gonzalez director, officer: Chief Executive Officer 15723 LAKE VERA PURDON RD., NEVADA CITY CA 95959
Eric Jason Watson director, officer: Chief Operating Officer 19553 BOWERS DRIVE, TOPANGA CA 90290

CuraScientific (CuraScientific) Headlines

From GuruFocus

Introducing Leaf of Faith

By Marketwired Marketwired 03-26-2019